EdenteV2, PubMed, Curation, bibRecord, 005F00

Sweeteners--an overview. Part. 1.

Identifieur interne : 005F00 ( PubMed/Curation ); précédent : 005E99; suivant : 005F01

Sweeteners--an overview. Part. 1.

Auteurs : J H Shaw

Source :

Dental abstracts; a selection of world dental literature [ 0011-8486 ] ; 1981.

RBID : pubmed:7014262

Descripteurs français

KwdFr :
- Acide glycyrrhizique, Aspartame (pharmacologie), Chalcone (analogues et dérivés), Chalcone (pharmacologie), Chalcones, Cyclamates (effets indésirables), Hespéridine (analogues et dérivés), Hespéridine (pharmacologie), Législation sur les produits chimiques ou pharmaceutiques, Mâchoire partiellement édentée (), Oxazines (pharmacologie), Polyols (pharmacologie), Saccharine (effets indésirables), Thiazines (pharmacologie), Xylitol (pharmacologie), Énoxolone (analogues et dérivés), Énoxolone (pharmacologie).
MESH :
- analogues et dérivés : Chalcone, Hespéridine, Énoxolone.
- effets indésirables : Cyclamates, Saccharine.
- pharmacologie : Aspartame, Chalcone, Hespéridine, Oxazines, Polyols, Thiazines, Xylitol, Énoxolone.
- Acide glycyrrhizique, Chalcones, Législation sur les produits chimiques ou pharmaceutiques, Mâchoire partiellement édentée.

English descriptors

KwdEn :
- Aspartame (pharmacology), Chalcone (analogs & derivatives), Chalcone (pharmacology), Chalcones, Cyclamates (adverse effects), Glycyrrhetinic Acid (analogs & derivatives), Glycyrrhetinic Acid (pharmacology), Glycyrrhizic Acid, Hesperidin (analogs & derivatives), Hesperidin (pharmacology), Jaw, Edentulous, Partially (therapy), Legislation, Drug, Oxazines (pharmacology), Saccharin (adverse effects), Sugar Alcohols (pharmacology), Thiazines (pharmacology), Xylitol (pharmacology).
MESH :
- chemical , adverse effects : Cyclamates, Saccharin.
- chemical , analogs & derivatives : Chalcone, Glycyrrhetinic Acid, Hesperidin.
- chemical , pharmacology : Aspartame, Chalcone, Glycyrrhetinic Acid, Hesperidin, Oxazines, Sugar Alcohols, Thiazines, Xylitol.
- chemical : Chalcones, Glycyrrhizic Acid.
- therapy : Jaw, Edentulous, Partially.
- Legislation, Drug.

PubMed: 7014262

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :005F00

Links to Exploration step

pubmed:7014262

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sweeteners--an overview. Part. 1.</title>
<author><name sortKey="Shaw, J H" sort="Shaw, J H" uniqKey="Shaw J" first="J H" last="Shaw">J H Shaw</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1981">1981</date>
<idno type="RBID">pubmed:7014262</idno>
<idno type="pmid">7014262</idno>
<idno type="wicri:Area/PubMed/Corpus">005F00</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005F00</idno>
<idno type="wicri:Area/PubMed/Curation">005F00</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005F00</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Sweeteners--an overview. Part. 1.</title>
<author><name sortKey="Shaw, J H" sort="Shaw, J H" uniqKey="Shaw J" first="J H" last="Shaw">J H Shaw</name>
</author>
</analytic>
<series><title level="j">Dental abstracts; a selection of world dental literature</title>
<idno type="ISSN">0011-8486</idno>
<imprint><date when="1981" type="published">1981</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aspartame (pharmacology)</term>
<term>Chalcone (analogs & derivatives)</term>
<term>Chalcone (pharmacology)</term>
<term>Chalcones</term>
<term>Cyclamates (adverse effects)</term>
<term>Glycyrrhetinic Acid (analogs & derivatives)</term>
<term>Glycyrrhetinic Acid (pharmacology)</term>
<term>Glycyrrhizic Acid</term>
<term>Hesperidin (analogs & derivatives)</term>
<term>Hesperidin (pharmacology)</term>
<term>Jaw, Edentulous, Partially (therapy)</term>
<term>Legislation, Drug</term>
<term>Oxazines (pharmacology)</term>
<term>Saccharin (adverse effects)</term>
<term>Sugar Alcohols (pharmacology)</term>
<term>Thiazines (pharmacology)</term>
<term>Xylitol (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acide glycyrrhizique</term>
<term>Aspartame (pharmacologie)</term>
<term>Chalcone (analogues et dérivés)</term>
<term>Chalcone (pharmacologie)</term>
<term>Chalcones</term>
<term>Cyclamates (effets indésirables)</term>
<term>Hespéridine (analogues et dérivés)</term>
<term>Hespéridine (pharmacologie)</term>
<term>Législation sur les produits chimiques ou pharmaceutiques</term>
<term>Mâchoire partiellement édentée ()</term>
<term>Oxazines (pharmacologie)</term>
<term>Polyols (pharmacologie)</term>
<term>Saccharine (effets indésirables)</term>
<term>Thiazines (pharmacologie)</term>
<term>Xylitol (pharmacologie)</term>
<term>Énoxolone (analogues et dérivés)</term>
<term>Énoxolone (pharmacologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Cyclamates</term>
<term>Saccharin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Chalcone</term>
<term>Glycyrrhetinic Acid</term>
<term>Hesperidin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Aspartame</term>
<term>Chalcone</term>
<term>Glycyrrhetinic Acid</term>
<term>Hesperidin</term>
<term>Oxazines</term>
<term>Sugar Alcohols</term>
<term>Thiazines</term>
<term>Xylitol</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Chalcones</term>
<term>Glycyrrhizic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Chalcone</term>
<term>Hespéridine</term>
<term>Énoxolone</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Cyclamates</term>
<term>Saccharine</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Aspartame</term>
<term>Chalcone</term>
<term>Hespéridine</term>
<term>Oxazines</term>
<term>Polyols</term>
<term>Thiazines</term>
<term>Xylitol</term>
<term>Énoxolone</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Jaw, Edentulous, Partially</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Legislation, Drug</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Acide glycyrrhizique</term>
<term>Chalcones</term>
<term>Législation sur les produits chimiques ou pharmaceutiques</term>
<term>Mâchoire partiellement édentée</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7014262</PMID>
<DateCompleted><Year>1981</Year>
<Month>07</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0011-8486</ISSN>
<JournalIssue CitedMedium="Print"><Volume>26</Volume>
<Issue>3</Issue>
<PubDate><Year>1981</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Dental abstracts; a selection of world dental literature</Title>
<ISOAbbreviation>Dent Abstr</ISOAbbreviation>
</Journal>
<ArticleTitle>Sweeteners--an overview. Part. 1.</ArticleTitle>
<Pagination><MedlinePgn>116-20</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shaw</LastName>
<ForeName>J H</ForeName>
<Initials>JH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Dent Abstr</MedlineTA>
<NlmUniqueID>60110120R</NlmUniqueID>
<ISSNLinking>0011-8486</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047188">Chalcones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003494">Cyclamates</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010078">Oxazines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013402">Sugar Alcohols</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013843">Thiazines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3X476D83QV</RegistryNumber>
<NameOfSubstance UI="C013613">neohesperidin dihydrochalcone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>5S5A2Q39HX</RegistryNumber>
<NameOfSubstance UI="D002599">Chalcone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>6FO62043WK</RegistryNumber>
<NameOfSubstance UI="D019695">Glycyrrhizic Acid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>E750O06Y6O</RegistryNumber>
<NameOfSubstance UI="D006569">Hesperidin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>FST467XS7D</RegistryNumber>
<NameOfSubstance UI="D012439">Saccharin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>MA3UYZ6K1H</RegistryNumber>
<NameOfSubstance UI="C006362">acetosulfame</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>P540XA09DR</RegistryNumber>
<NameOfSubstance UI="D006034">Glycyrrhetinic Acid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>VCQ006KQ1E</RegistryNumber>
<NameOfSubstance UI="D014993">Xylitol</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Z0H242BBR1</RegistryNumber>
<NameOfSubstance UI="D001218">Aspartame</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>D</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001218" MajorTopicYN="N">Aspartame</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002599" MajorTopicYN="N">Chalcone</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D047188" MajorTopicYN="N">Chalcones</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003494" MajorTopicYN="N">Cyclamates</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006034" MajorTopicYN="N">Glycyrrhetinic Acid</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019695" MajorTopicYN="N">Glycyrrhizic Acid</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006569" MajorTopicYN="N">Hesperidin</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007576" MajorTopicYN="N">Jaw, Edentulous, Partially</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007880" MajorTopicYN="N">Legislation, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010078" MajorTopicYN="N">Oxazines</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012439" MajorTopicYN="N">Saccharin</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013402" MajorTopicYN="N">Sugar Alcohols</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013843" MajorTopicYN="N">Thiazines</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014993" MajorTopicYN="N">Xylitol</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>17</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1981</Year>
<Month>3</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1981</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1981</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">7014262</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005F00 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 005F00 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:7014262
   |texte=   Sweeteners--an overview. Part. 1.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:7014262" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a EdenteV2

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022

	Serveur d'exploration sur le patient édenté
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le patient édenté

Sweeteners--an overview. Part. 1.

Sweeteners--an overview. Part. 1.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki